chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient felt light-headed and sick after receiving vaccination, Patient was given a cold compress. shortly thereafter patient stopped talking and pupils became dilated. Patient was seated at time of vaccination, their head rolled back and patient began to seize. Patient lost pulse for a few moments (roughly 1-2 minutes). Patient then regained consciousness. EMS arrived and took over patient observation and checked then cleared patient. patient then left with family member
This spontaneous report was received from a registered nurse and refers to unspecified number of patients of unknown age and gender. No information regarding the patients' pertinent medical history, concomitant medications, drug reactions or allergies was provided. On unspecified dates, those patients were administered doses of improperly stored doses of ROTATEQ lot# M035456, expiration date: 01-MAY-2018 (dosage and route were not reported). No adverse events were reported. Vaccines were stored in the temperature of 47 to 77 degrees Fahrenheit for 18 hours. On 16-AUG-2017 a call was placed to the reporter. All telephone attempts to obtain follow-up information have been unsuccessful. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1707USA005591: Original Case: 1707USA005591.
This case was reported by a other health professional via sales rep and described the occurrence of joint range of motion decreased in a 38-year-old female patient who received BOOSTRIX (batch number 54B74, expiry date unknown). On 7th May 2018, the patient received BOOSTRIX. On 8th May 2018, 1 days after receiving BOOSTRIX, the patient experienced joint range of motion decreased and pain in arm. In May 2018, the patient experienced bursitis. On an unknown date, the outcome of the joint range of motion decreased, pain in arm and bursitis were not recovered/not resolved. It was unknown if the reporter considered the joint range of motion decreased, pain in arm and bursitis to be related to BOOSTRIX. Additional details were provided as follows: The patient experienced ongoing pain and restricted range of movement of left shoulder and chemical bursitis which was ongoing at the time of reporting. The reporter thought the vaccine was administered incorrectly (not further specified).
laying in hospital beds for the past 3 weeks; open wound; scabs; Suspected vaccination failure; has it on buttocks; bedsore; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. In January 2022, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced bedridden (serious criteria hospitalization). On an unknown date, the patient experienced suspected vaccination failure (serious criteria GSK medically significant), shingles, bed sore, open wound and scab. On an unknown date, the outcome of the suspected vaccination failure was unknown and the outcome of the shingles, bed sore, bedridden, open wound and scab were not recovered/not resolved.   It was unknown if the reporter considered the suspected vaccination failure, shingles, bed sore, bedridden, open wound and scab to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: The patient was reporter's mother. Age at vaccination was not reported. The patient received 2 doses of Shingles vaccine 2 years before the date of reporting. The reporter stated that an advanced registered nurse practitioner (ARNP) stated that it on her buttocks.  The reporter stated it was a bedsore from laying in hospital beds for the past 3 weeks. There was no blistering but an open wound that scabs over. The reporter asked if it was possible. This case was considered as suspected vaccination fialure since the details regarding laboratory test confirming shingles were not available at the time of reporting. Consent to follow up was not possible as no contact details were available.
dizzy spell; Spinning feeling of heat from her feet to her head; stomach pains/stomach hurts when eating; stomach muscle spasms; possible weight gain; feels cold all the time; easy bruising; This is a spontaneous report from a non-contactable consumer (patient). A 73-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history included car accident in November in hospital for 2 days. The patient's concomitant medication included nilotinib hydrochloride (TASIGNA) ate food after it one day. The patient experienced dizzy spell, felt like spinning feeling of heat from her feet to her head day after COVID vaccine on an unspecified date. The patient had stomach pain/stomach hurts when eating and stomach muscle spasms, possible weight gain, feels cold all the time and easy bruising on an unspecified date. The outcome was unknown at the reporting time.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Nausea,  chills, fever, headache and body aches as well as cramps in the feet.
Suffered a stroke; blood clots in the brain; This is a spontaneous report from a contactable consumer (patient). A 72-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration, administered on the left arm on 04Jan2021 14:00 at a single dose for COVID-19 immunisation. Medical history included heart valve replacement, thyroid issues and headache. Concomitant medications included medications in the last two weeks (unspecified). The patient previously received first dose of BNT162B2 on an unknown date for COVID-19 immunization. On 24Feb2021 12:00 PM, the patient suffered a stroke - blood clots in the brain. Had brain scans earlier in the year for headaches but nothing found. The events resulted to doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event)]. The patient was hospitalized for the events for 7 days. Therapeutic measures were taken as a result of the events which included surgery to break and remove the clot. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. No known allergies. The facility where the vaccine was administered was in a Public Health Clinic facility. Patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Outcome of the events was recovered on an unspecified date.   Information about lot/batch number has been requested.
Right upper arm pain/redness/swelling - golf ball sized starting 1/23/2021.  Mild itching at onset, now resolved.   No other sx.
Hospitalization: 1/29/2023 - 1/31/2023 (2 days) Presentation to the ED: left facial droop.  COVID + date: 1/30/2023 Treatment: none. patient was asymptomatic.  Discharge to: home.   027A21A 3/9/21 032H21A 12/16/21
At 48 hours, I was unable to sleep (insomnia) and up for 21 hours.  I have never experienced that before.  By 72 hours, I was still waking up with headaches, was  very dizzy throughout the day, decreased appetite, diarrhea and nausea.
At time of Garasil vaccine injection to LD IM pt immediately felt severe pain at site of injection, felt dizzy lighthead, hot and sweaty. Pain 6/10. Within 15 mins time pts color return to lips and face completely. Slight darken redness noted to skin below eyes.
Patient's mother reported that  patient developed a rash on her face that lasted almost 8 days. Her mother denied giving patient any medications to help with the rash. Per her mother, the rash resolved on her own.
Dry cough began on 4/15/01. Pt seen on 4/16/01 and Prevnar given. On 4/16/01 PM, pt had increased difficulty breathing. He was hospitalized on 4/17/01 and required transport to PICU on 4/17/01 for heliox treatment.  Diagnosed with viral pneumonia.
coughing; This is a spontaneous report received from a contactable consumer (patient herself) or other non HCP via Medical Information Team. This consumer reported adverse events with similar suspect for 2 patients. This report is One of two patients.   A 59-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on 29May2021 as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. The patient's medical history included covid-19 on an unknown date in Sep2020 (reported as last September). The patient's concomitant medications were not reported. On an unknown date, after 5 days, the patient was coughing, and it was for 11 days. The patient still having complaints of cough. The patient  scheduled for second dose of Pfizer Covid-19 Vaccine on 19JUN2021 and wanted to know if she should I take vaccine on Saturday. The outcome of the event was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021705255 same report/drug/AE, different patient
Pain in the arm from chest to hand, pain and tenderness of the lymph node in the arm of the injection, started near 7:00 pm. Became very sleepy + blur vision. Near 9:00 pm fever started. All night have troubles with sleeping: nightmares and and waking up many times. In the morning: feel seek ( sensitive lymph nodes behind the ears, headache).
Monovalent vaccine administered for a booster on 9-2-22. Bivalent booster authorized by FDA on 8/31/22. Patient contacted, will return for bivalent booster in 2 months.
rash; got like a burning fever; I just have sweat , I just had bad sweat; This is a spontaneous report from a contactable consumer (patient) or other non HCP.  A 51-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0173; Expiration date: Jul2021), via an unspecified route of administration on 04Apr2021 (age at vaccination was 51 years-old) as Dose 1, SINGLE for covid-19 immunisation; patient received diphenhydramine hydrochloride (BENADRYL), Batch/Lot number: Unknown), via an unspecified route of administration from an unspecified date to an unspecified date for an unspecified indication. The patient medical history was not reported. Concomitant medications included lisinopril taken for blood pressure, rosuvastatin calcium (CRESTOR) taken for cholesterol, methadone taken for back surgery; start and stop date were not reported for all. On an unspecified date in Apr2021, patient experienced rash, got like a burning fever, just had bad sweat. he just had sweat and he just had bad sweat with it and the patient meant that the first start he had with bnt162b2 and he got a rash, he got like a burning fever. The patient's initials was confirmed. Investigation assessment was not reported. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
she has a blood clot; had a blood clot and it looked like dark red bruises on the left side of her chest; This is a spontaneous report from a Pfizer sponsored program COVAX US support from a contactable consumer (patient). A female patient of unknown age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 27Apr2021 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 on 06Apr2021. The patient had a blood clot and it looked like dark red bruises on the left side of her chest. She just noticed it after she received her 2nd dose on 27Apr2021. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Painful left thigh swelling to approximately twice normal diameter. No impairment of walking and no signs of infection, improving at time of office visit 1/23/08 at 9:30am.
he couldn't work for 3 days after taking the Moderna booster dose; This spontaneous case was reported by a consumer and describes the occurrence of IMPAIRED WORK ABILITY (he couldn't work for 3 days after taking the Moderna booster dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMPAIRED WORK ABILITY (he couldn't work for 3 days after taking the Moderna booster dose). At the time of the report, IMPAIRED WORK ABILITY (he couldn't work for 3 days after taking the Moderna booster dose) had resolved.            Concomitant medications were not reported. Treatment medications were not reported
My lymph nodes under my left arm started causing discomfort on Sunday night following the vaccination to my left arm on Saturday evening. As of this morning (Thurday monring) my lymph nodes are still swollen and the pressure/discomfort has reduced somewhat. Tender when touched or with some movements.
3 hours post injection, hives erupted on scalp, neck, face, torso and arms. Treated with topical tea tree oil and topical benedryl. Added benedryl pill 3 hours later.  Hives remained for 30 hours. Minor outbreaks on back and scalp today, 48 hours post shot.
Vaccine Clinic: Patient  (10/29/44) received her 2nd dose of the Moderna Vaccine today.  She and her son waited in the observation area for 15 minutes and when they getting ready to leave, Patient  stood up and felt weak and dizzy.  Son sat her back down in the chair and the nursing student called out for my attention.  I went over and assessed the patient. MA went and got a manual BP cuff.  Patient reported weakness and dizziness.  I asked a team member to get Dr. and he quickly came over and assessed the patient.  He advised that the patient stay in observation another 20-30 minutes and report any changes.  I offered water and a snack, but patient refused.  We had the patient and son stay as instructed.  About 25 minutes later, the patient was more alert and reported feeling better. I offered to wheel her out in a wheelchair and she refused.  Son also stated that she is doing better. Patient and son, were escorted out the vaccine clinic. No other issues reported.
feeling crappy; no energy; freezing my butt off due to the fever; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feeling crappy), ASTHENIA (no energy), HYPOAESTHESIA (freezing my butt off due to the fever) and PYREXIA (low grade fever) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 054H21A, 002C21A and 045A21A) for COVID-19 vaccination.     Concurrent medical conditions included HIV infection (undetectable HIV).   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (feeling crappy), ASTHENIA (no energy), HYPOAESTHESIA (freezing my butt off due to the fever) and PYREXIA (low grade fever). At the time of the report, FEELING ABNORMAL (feeling crappy), ASTHENIA (no energy), HYPOAESTHESIA (freezing my butt off due to the fever) and PYREXIA (low grade fever) was resolving.            Concomitant medication of the patient was unknown.  The patient received unknown corrective treatment for the events. The symptoms of the patient some sort of wearing off.   This case was linked to MOD-2021-419311, MOD-2021-419320 (Patient Link).
Extreme light headed and dizziness beginning 10 mins after vaccination that progressed over the hour. Migraine Within an hour which lasted 24 hours. Extremely fatigued, nausea & ?out-of-body? feeling within the first 24 hours.  Headache over Left eye for entire 2nd- 4th day.  Headache gone day 5 and felt normal. Breasts have been and very tender especially the past 2 days. This is very abnormal. no chance of pregnancy as my partner has had a vasectomy.
Slight fever (100), slight headache,  bumps on skin 2" from injection location,  pink, warm area  4" from injection and  lump on lower  part of upper arm (6" from injection) tender to the touch. Noticed 20 hrs post-injection,  headache and fever gone by 24 hrs post-injection but reaction on arm still  there 4 days later, only slightly reduced.
No adverse reaction reported; The patient "pulled away" during vaccine andministration and only partial dose was administered; The patient "pulled away" during vaccine andministration and only partial dose was administered; Some of the vaccine may have gotten on the patient's skin; This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history and concomitant therapy were not reported.    On 13-MAY-2019,  the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II), subcutaneously (lot #  R036581, expiration date 17-DEC-2020) (dose not reported)  for prophylaxis.  The vaccine was reconstituted with sterile diluent (lot # S008565, expiration date 09-AUG-2021).      The patient "pulled away" during administration of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) and as a result, only a partial dose was administered. Medical assistant reported that some of the vaccine may have gotten on the patient's skin. No adverse reaction was reported.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-1905USA009445:Original Case : 1905USA009408
No additional AEs reported; GARDASIL 9 was administered following a temperature excursion; This spontaneous report was received from an office manager referring to a 12-year-old male patient.  The patient's concurrent conditions, medical history, and concomitant therapies were not reported.  On 24-OCT-2022, the patient was vaccinated with one dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) pre-filled syringe injection, administered as prophylaxis (there were five possible lot # of the vaccine administered: lot #1775811, expiration date: 07-DEC-2023; lot #1775827, expiration date: 27-JUN-2024; lot #W009829, expiration date: 19-OCT-2024; lot #U032681, expiration date: 26-OCT-2023; and lot #1780876, expiration date: 09-NOV-2023; however, it was not specified which one was received by the patient) (strength, dose, route of administration, anatomical location, and vaccination scheme were not provided). It was reported that the vaccines suffered from three temperature excursions with a total of 25 minutes (on 09-SEP-2022 for 8 minutes; on 16-SEP-2022 for 5 minutes; and on 03-JAN-2023 for 12 minutes). The excursions were not noted until it was noticed that an employee mistakenly cleaned the data logger more than once a day (product storage error). There were no additional adverse events (AEs) reported in the patient (no adverse event).  This is one of several reports received from the same reporter.
Subsequent to receiving first and second doses of Havrix, the pt was sent to Central America to do missionary work and contracted Hepatitis A. As of 02/06/2001 the outcome of the event is unknown.
Hand doesn't stop hurting; The left arm (where the patient received the injection) from the shoulder down to the elbow the patient could not move it; Cannot move my hands and hands are completely dead; It has gone worse over time; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Hand doesn't stop hurting), VACCINATION SITE MOVEMENT IMPAIRMENT (The left arm (where the patient received the injection) from the shoulder down to the elbow the patient could not move it), HYPOAESTHESIA (Cannot move my hands and hands are completely dead) and CONDITION AGGRAVATED (It has gone worse over time) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Aug-2021, the patient experienced PAIN IN EXTREMITY (Hand doesn't stop hurting), VACCINATION SITE MOVEMENT IMPAIRMENT (The left arm (where the patient received the injection) from the shoulder down to the elbow the patient could not move it), HYPOAESTHESIA (Cannot move my hands and hands are completely dead) and CONDITION AGGRAVATED (It has gone worse over time). At the time of the report, PAIN IN EXTREMITY (Hand doesn't stop hurting), VACCINATION SITE MOVEMENT IMPAIRMENT (The left arm (where the patient received the injection) from the shoulder down to the elbow the patient could not move it), HYPOAESTHESIA (Cannot move my hands and hands are completely dead) and CONDITION AGGRAVATED (It has gone worse over time) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No concomitant product use was provided by the reporter.    No treatment medications were reported.
Initial vacines done in Feb and March.  This was a booster. Started Friday evening with body aches, extreme joint pain, then chills, headache, and fatigue.  About 3am nauseated and vomited.  Felt disorientated, tired and slept off an on from midnight Friday until 3pm Sat afternoon.  Still nauseated, unable to eat.  Slept again from 9pm Sat until 8am Sunday when I began to feel better.  Headache lingered until Mon morning.  Monday, felt tired, but ok
Red swollen area over (R) arm. Area is red and swollen and warm. Area is nontender to touch. Rx for Augmentin 875 mg T bid #20 to be filled if not better in the next 24 period
A non-serious spontaneous report of a 63 year old female received a dose of H1N1 was received from a registered nurse/health professional concerning a 63-year-old female. Neither relevant medical history nor concomitant medication have been reported for this patient. On 12-Jan-2010 the patient received the H1N1, Intranasal an unknown indication. There was no adverse event associated with this medication error; therefore treatment and reporter causality assessments are not applicable, and the event is considered resolved.
new onset sz on 11JAN99;dx as infantile spasms;Annual follow-up dated 09/27/00 states the pt has lower face weakness, righ hemiparesis, left hemi spherectomy.